IDENTIFICATION AND QUANTIFICATION OF PHOSPHODIESTERASE-5 INHIBITORS AS ADULTERANTS IN DIETARY SUPPLEMENTS MARKED FOR SEXUAL ENHANCEMENT IN THE LEBANESE MARKET

  • RAZAN SOUBRA Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon
  • AZZA A. GAZY Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon
  • MAY SAAB Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon
  • MARWA K. AL JAMAL Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon

Abstract

Objective: Ultraviolet Visible spectrophotometric was adopted to identify and quantify any adulteration with PDE-5 inhibitors (Sildenafil and Tadalafil) in selected dietary supplements used for sexual enhancement in the Lebanese market


Methods: Nine dietary supplements, randomly collected from Lebanese pharmacies, were screened for Sildenafil and Tadalafil using UV-spectrophotometry for both qualitative and quantitative detection.


Results: Tadalafil was detected in one sample at a dose of 59 mg/dosage unit, with the maximal recommended dose being 20 mg. Sildenafil was detected in five samples at doses ranging from 11.7 to 188.2 mg/dosage unit, with the maximal recommended dose being 100 mg.


Conclusion: This study demonstrates that regular analysis of supposed dietary supplements is needed for more effective quality control and health promotion. The method described for the extraction, identification and quantification of Tadalafil and Sildenafil would be useful for regulatory detection of adulterations.

Keywords: Adulteration, PDE-5 inhibitors, Sildenafil, Tadalafil, Herbal supplements, Spectrophotometry

Downloads

Download data is not yet available.

References

1. Skalicka Wozniak K, Georgiev MI, Orhan IE. Adulteration of herbal sexual enhancers and slimmers: the wish for better sexual well-being and perfect body can be risky. Food Chem Toxicol 2017;108:355–64.
2. Bhagavathula AS, Elnour AA, Shehab A. Pharmacovigilance on sexual enhancing herbal supplements. Saudi Pharm J 2016;24:115–8.
3. Mustabasic N, Isik S. Determination of sildenafil mixed into herbal honey mixture by ultra-performance liquid chromatography-quadrupole time of flight mass spectrometry. Croat J Food Sci Technol 2017;9:168–72.
4. Ekar T, Kreft S. Common risks of adulterated and mislabeled herbal preparations. Food Chem Toxicol 2019;123:288–97.
5. Fard HH, Akhgari M. Analytical perspectives of chemical adulterants in herbal sexual enhancer drugs. J Pharm Pharmacol 2018;6:45–53.
6. Mohammad Al-Amin, Gazi N Sultana, Chowdhury F. Hossain identification of sildenafil citrate as an adulterant in herbal products using high-performance liquid chromatography with photodiode array detector. Int J Pharm Pharm Sci 2018;10:15-20.
7. Zuntar I, Krivohlavek A, Kosic Vuksic J, Granato D, Bursac Kovacevic D, Putnik P. Pharmacological and toxicological health risk of food (herbal) supplements adulterated with erectile dysfunction medications. Curr Opin Food Sci 2018;24:9–15.
8. Campbell N, Clark JP, Stecher VJ, Thomas JW, Callanan AC, Donnelly BF, et al. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med 2013;10:1842–9.
9. Gilard V, Balayssac S, Tinaugus A, Martins N, Martino R, Malet Martino M. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance. J Pharm Biomed Anal 2015;102:476–93.
10. Bujang NB, Chee CF, Heh CH, Rahman NA, Buckle MJC. Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014–16. Food Addit Contam Part A 2017;34:1101–9.
11. ElAgouri G, ElAmrawy F, ElYazbi A, Eshra A, Nounou MI. Male enhancement nutraceuticals in the middle east market: claim, pharmaceutical quality and safety assessments. Int J Pharm 2015;492:109–19.
12. Rocha T, Amaral JS, Oliveira MBPP. Adulteration of dietary supplements by the illegal addition of synthetic drugs: a review. Compr Rev Food Sci Food Saf 2016;15:43–62.
13. Clahan J, Howard D, J Almalki A, P Gupta M, L Calderon A. Chemical adulterants in herbal medicinal products: a review. Planta Med 2016;82:505–15.
14. Amir A Sakur, Shaza A. Validated spectrophotometric method to determine vardenafil and sildenafil in pharmaceutical forms using potassium iodide and potassium iodate. Int J Pharm Pharm Sci 2017;9:65-9.
15. Baokar S, Pawar V, Patil RN, Jagatap R, Ekatpure N. Validation of simple and rapid UV-spectrophotometric method with stress degradation study for sildenafil citrate. Res J Pharm Technol 2012;5:214–8.
16. Yunoos M, Sankar DG, Kumar BP, Hameed S. UV spectrophotometric method for the estimation of tadalafil in bulk and tablet dosage form. E J Chem 2010;7:833–6.
17. Elrasheed G, Magdi Awadalla M, SM A. Adulteration of herbal preparations with sildenafil and tadalafil. The Sixth Annual Post-graduate Studies and Scientific Research Conference. Khartoum, Sudan; 2015.
18. Agrawal SS, Mishra G. Adulteration of synthetic PDE-5 inhibitors viz., sildenafil and tadalafil in marketed herbal aphrodisiacs. Curr Med Res Pract 2016;6:152–6.
19. WHO. Definitions of substandard and falsified (SF) medical products. WHO. World Health Organization; 2017. Available from: https://www.who.int/medicines/regulation/ssffc/ definitions/en/ [Last accessed on 29 Sep 2019]
20. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. Available from: https://apps.who.int/medicinedocs/en/m/abstract/Js7148e/ [Last accessed on 29 Sep 2019]
21. Decree 5518 concerning the regulation of import, export, sale, manufacture, and packaging of food supplements and natural products of health benefits and the determination of the relevant committee and compensation of its sessions. Lebanese Ministry of Public Health; 2010. Available from: https://www.moph.gov.lb/userfiles/files/SanitaryEngineering/FoodSupplements/Decree 5518-10.pdf. [Last accessed on 14 Dec 2010]
22. Decision of the Minister of Health No. 841 concerning the control over the marketing of therapeutic preparations and dietary supplements. Lebanese Ministry of Public Health; 2012. Available from: https://www.moph.gov.lb/userfiles/files/SanitaryEngineering/FoodSupplements/karar841-2012.pdf [Last accessed on 22 Jul 2012].
Statistics
157 Views | 132 Downloads
Citatons
How to Cite
SOUBRA, R., A. A. GAZY, M. SAAB, and M. K. AL JAMAL. “IDENTIFICATION AND QUANTIFICATION OF PHOSPHODIESTERASE-5 INHIBITORS AS ADULTERANTS IN DIETARY SUPPLEMENTS MARKED FOR SEXUAL ENHANCEMENT IN THE LEBANESE MARKET”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 12, no. 3, Jan. 2020, pp. 57-62, doi:10.22159/ijpps.2020v12i3.36527.
Section
Original Article(s)